US Patent Issued to Metabolic Technologies on Jan. 28 for "Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma" (Iowa, Tennessee Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,073, issued on Jan. 28, was assigned to Metabolic Technologies LLC (Missoula, Mont.).

"Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma" was invented by Shawn Baier (Polk City, Iowa), Naji Abumrad (Nashville, Tenn.) and Emily Harris (Grimes, Iowa).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a composition comprising HMB. Methods of administering HMB to an animal are also described. HMB is administered to enhance recovery from soft tissue trauma, including both acute and non-acute soft tissue trauma. Enhanced recovery includes reduced recovery time...